KERGET, B. Et Al. 2024. COMPARISON OF METHOTREXATE AND METHYLPREDNISOLONE AS ADDITION TO ANTIFIBROTIC THERAPY IN PROGRESSIVE PULMONARY FIBROSIS DUE TO COVID-19. SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , no.4 .

KERGET, B., TOPAL, B. N., Cinar, I., ALPER, F., & SAĞLAM, L., (2024). COMPARISON OF METHOTREXATE AND METHYLPREDNISOLONE AS ADDITION TO ANTIFIBROTIC THERAPY IN PROGRESSIVE PULMONARY FIBROSIS DUE TO COVID-19. SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , no.4.

KERGET, Buğra Et Al. "COMPARISON OF METHOTREXATE AND METHYLPREDNISOLONE AS ADDITION TO ANTIFIBROTIC THERAPY IN PROGRESSIVE PULMONARY FIBROSIS DUE TO COVID-19," SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , no.4, 2024

KERGET, Buğra Et Al. "COMPARISON OF METHOTREXATE AND METHYLPREDNISOLONE AS ADDITION TO ANTIFIBROTIC THERAPY IN PROGRESSIVE PULMONARY FIBROSIS DUE TO COVID-19." SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , no.4, 2024

KERGET, B. Et Al. (2024) . "COMPARISON OF METHOTREXATE AND METHYLPREDNISOLONE AS ADDITION TO ANTIFIBROTIC THERAPY IN PROGRESSIVE PULMONARY FIBROSIS DUE TO COVID-19." SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , no.4.

@article{article, author={Buğra KERGET Et Al. }, title={COMPARISON OF METHOTREXATE AND METHYLPREDNISOLONE AS ADDITION TO ANTIFIBROTIC THERAPY IN PROGRESSIVE PULMONARY FIBROSIS DUE TO COVID-19}, journal={SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES}, year=2024}